Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies
Birdwell, Kelly A.
Rangaswami, Janani
Mathew, Roy O.
Parasuraman, Raviprasenna
Tantisattamo, Ekamol
:
2019-05
Abstract
Kidney transplantation (KT) is the optimal therapy for end-stage kidney disease (ESKD), resulting in significant improvement in survival as well as quality of life when compared with maintenance dialysis. The burden of cardiovascular disease (CVD) in ESKD is reduced after KT; however, it still remains the leading cause of premature patient and allograft loss, as well as a source of significant morbidity and healthcare costs. All major phenotypes of CVD including coronary artery disease, heart failure, valvular heart disease, arrhythmias and pulmonary hypertension are represented in the KT recipient population. Pre-existing risk factors for CVD in the KT recipient are amplified by superimposed cardio-metabolic derangements after transplantation such as the metabolic effects of immunosuppressive regimens, obesity, posttransplant diabetes, hypertension, dyslipidemia and allograft dysfunction. This review summarizes the major risk factors for CVD in KT recipients and describes the individual phenotypes of overt CVD in this population. It highlights gaps in the existing literature to emphasize the need for future studies in those areas and optimize cardiovascular outcomes after KT. Finally, it outlines the need for a joint 'cardio-nephrology' clinical care model to ensure continuity, multidisciplinary collaboration and implementation of best clinical practices toward reducing CVD after KT.
Files in this item
This item appears in the following collection(s):
Related items
Showing items related by title, author, creator and subject.
-
Guterman, Jessica; Glazer, Michael (Vanderbilt University. Human Resources, 2010-03-12)Jessica Guterman, Vanderbilt Dietetic Intern interviews Vanderbilt Cardiologist Michael Glazer, MD on the shocking statistics associated with heart disease as well as details on how to assess and reduce your personal risk.
-
Fogo, Agnes B. (Vanderbilt University. Medical Center, 2007-07-06)
-
Turner, Stephen Dale (2010-12-21)Department: Human GeneticsGrowing interest and burgeoning technology for discovering genetic mechanisms that influence disease processes have ushered in a flood of genetic association studies over the last decade, yet little heritability in highly ...